Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. | 2,981,592 | reported | 16 Aug 2022 | tx 4+4,124,239 |
| IMPEL NEUROPHARMA INC | 2,029,495 | reported | 19 Dec 2023 | tx 30+2,884,789−36,732,790 |
| Crinetics Pharmaceuticals, Inc. | 298,625 | reported | 17 Apr 2020 | tx 6−330,598 |
| Bolt Biotherapeutics, Inc. | 269,823 | reported | 20 Nov 2023 | tx 9−86,054 |
| Aligos Therapeutics, Inc. | 0 | reported | 20 Oct 2020 | tx 14+3,547,030−2,997,030 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Dec 2023 | SALE | IMPEL NEUROPHARMA INC | 12,066 | 0.29 USD | |
| 19 Dec 2023 | SALE | IMPEL NEUROPHARMA INC | 28,632 | 0.08 USD | |
| 19 Dec 2023 | SALE | IMPEL NEUROPHARMA INC | 208,657 | 0.08 USD | |
| 15 Dec 2023 | SALE | IMPEL NEUROPHARMA INC | 87,934 | 0.29 USD | |
| 18 Dec 2023 | SALE | IMPEL NEUROPHARMA INC | 209,029 | 0.11 USD | |
| 18 Dec 2023 | SALE | IMPEL NEUROPHARMA INC | 28,682 | 0.11 USD | |
| 20 Nov 2023 | SALE | Bolt Biotherapeutics, Inc. | 23,443 | 0.92 USD | |
| 16 Nov 2023 | SALE | Bolt Biotherapeutics, Inc. | 7,531 | 0.96 USD | |
| 16 Nov 2023 | SALE | Bolt Biotherapeutics, Inc. | 1,040 | 0.96 USD | |
| 16 Nov 2023 | SALE | Bolt Biotherapeutics, Inc. | 6,429 | 0.96 USD | |
| 20 Nov 2023 | SALE | Bolt Biotherapeutics, Inc. | 3,792 | 0.92 USD | |
| 17 Nov 2023 | SALE | Bolt Biotherapeutics, Inc. | 1,134 | 0.93 USD | |
| 17 Nov 2023 | SALE | Bolt Biotherapeutics, Inc. | 7,009 | 0.93 USD | |
| 20 Nov 2023 | SALE | Bolt Biotherapeutics, Inc. | 27,465 | 0.92 USD | |
| 17 Nov 2023 | SALE | Bolt Biotherapeutics, Inc. | 8,211 | 0.93 USD | |
| 15 Aug 2022 | PURCHASE | Terns Pharmaceuticals, Inc. | 1,218 | 2.99 USD | |
| 12 Aug 2022 | PURCHASE | Terns Pharmaceuticals, Inc. | 1,123,021 | 2.98 USD | first after silence |
| 16 Aug 2022 | PURCHASE | Terns Pharmaceuticals, Inc. | 1,500,000 | 2.42 USD | |
| 16 Aug 2022 | PURCHASE | Terns Pharmaceuticals, Inc. | 1,500,000 | 2.42 USD | deriv |
| 27 Apr 2021 | CONVERSION | IMPEL NEUROPHARMA INC | 710,190 | — | |
| 27 Apr 2021 | CONVERSION | IMPEL NEUROPHARMA INC | 98,068 | — | |
| 27 Apr 2021 | CONVERSION | IMPEL NEUROPHARMA INC | 474,713 | — | |
| 27 Apr 2021 | CONVERSION | IMPEL NEUROPHARMA INC | 65,552 | — | |
| 27 Apr 2021 | CONVERSION | IMPEL NEUROPHARMA INC | 440,119 | — | |
| 27 Apr 2021 | CONVERSION | IMPEL NEUROPHARMA INC | 60,813 | — |
1 purchase reported after at least 12 months of silence — most recent on 12 Aug 2022.